Alice Tien, Managing Director of Biogen Australia and New Zealand, said, “People living with ALS and those who support them have waited a long time to see meaningful progress against this devastating disease." …
TGA provisional approval brings first targeted treatment for SOD1 linked ALS to Australia
June 1, 2026 Latest NewsBioPharma
Latest Video
New Stories
-
TGA provisional approval brings first targeted treatment for SOD1 linked ALS to Australia
June 1, 2026 - - Latest News -
Helpful evidence of how the review is landing on outcomes to potentially benefit a few 'Unicorns'
June 1, 2026 - - Latest News -
Australia's HTA Review closed-loop process continues with 'Delphi' stage two
June 1, 2026 - - Latest News -
New Zealand's pre-election Budget boosts health spending, but Pharmac misses out
May 29, 2026 - - Latest News -
The 'Dispatched' Week in Review Podcast - 29 May
May 28, 2026 - - Podcast -
AusBiotech unites conferences under the banner of the 'Biggest Week' in biotech
May 28, 2026 - - Australian Biotech -
Research highlighting gaps leaving some communities at greater risk as flu
May 28, 2026 - - Latest News